Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net Income (Loss)	$ (15,387,309)	$ (14,850,943)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	19,705	170,830
Stock-based compensation expense	232,155	377,899
Non-cash consulting and marketing fees	0	17,280
Changes in operating assets and liabilities:
Accounts receivable	0	39,881
Operating lease right-of-use assets	89,122	78,553
Prepaid expenses and other assets	698	(208,086)
Prepaid research and development	107,592	770,051
Accounts payable	1,329,135	(416,612)
Operating lease liabilities	(95,009)	(81,244)
Accrued expenses and other current liabilities	(98,581)	(540,221)
Net cash used in operating activities	(13,802,492)	(14,642,612)
Cash flows from investing activities
Purchases of equipment and improvements	0	(14,238)
Purchases of investments - marketable securities	(10,343,939)	(20,629,391)
Maturities of investments - marketable securities	12,101,463	34,415,890
Net cash provided by investing activities	1,757,524	13,772,261
Cash flows from financing activities
Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs	3,793,209	8,543,107
Net cash provided by financing activities	3,793,209	8,543,107
Net (decrease) increase in cash and cash equivalents	(8,251,759)	7,672,756
Cash and cash equivalents at beginning of period	9,165,179	7,188,553
Cash and cash equivalents at end of period	913,420	14,861,309
Supplemental disclosures of non-cash financing activities
Non-cash financing costs	553,318	0
Supplemental disclosures of cash flow information
Issuance costs	$ 1,203,350	$ 1,456,479